Cargando…
Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer
BACKGROUND: Thymoquinone (TQ) was shown to reduce tumor growth in several cancer models both in vitro and in vivo. So far only a few targets of TQ, including protein kinases have been identified. Considering that kinases are promising candidates for targeted anticancer therapy, we studied the comple...
Autores principales: | El-Baba, Chirine, Mahadevan, Vijayalakshmi, Fahlbusch, Fabian B, S, Suma Mohan, Rau, Tilman T, Gali-Muhtasib, Hala, Schneider-Stock, Regine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158125/ https://www.ncbi.nlm.nih.gov/pubmed/25174975 http://dx.doi.org/10.1186/1476-4598-13-201 |
Ejemplares similares
-
Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells
por: Fatfat, Zaynab, et al.
Publicado: (2021) -
Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells
por: Ndreshkjana, Benardina, et al.
Publicado: (2019) -
Thymoquinone enhances the antioxidant and anticancer activity of Lebanese propolis
por: AlDreini, Sima, et al.
Publicado: (2023) -
Thymoquinone anticancer activity is enhanced when combined with royal jelly in human breast cancer
por: Moubarak, Maya M, et al.
Publicado: (2021) -
Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models
por: Gali-Muhtasib, Hala, et al.
Publicado: (2008)